Clinical Trial Update: Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 study evaluating extracorporeal photopheresis for chronic graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Graft vs Host Disease | Phase 2 | Status: COMPLETED